Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Decibel Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 36 | 40 | +4 |
| Shares | 18.9M | 17.6M | −1.36M (−7.2%) |
| Value | $145.9M | $81.7M | −$64.2M (−44.0%) |
New holders (10)
Institutions that held Decibel Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 50,900 | $237.0K | 0.00% |
| Two Sigma Investments, LP | 47,368 | $220.0K | 0.00% |
| Marquette Asset Management, LLC | 18,472 | $86.0K | 0.02% |
| Two Sigma Advisers, LP | 11,300 | $53.0K | 0.00% |
| Flagship Harbor Advisors, LLC | 10,113 | $47.0K | 0.00% |
| Acadian Asset Management LLC | 4,283 | $19.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,409 | $7.00K | 0.00% |
| Citigroup Inc | 751 | $3.00K | 0.00% |
| Financial Connections Group, Inc. | 300 | $1.00K | 0.00% |
| UBS Group AG | 95 | $0 | 0.00% |
Sold out (6)
Institutions that held Decibel Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Foresite Capital Management IV, LLC | 297,711 | $2.29M |
| Credit Suisse AG | 251,950 | $1.94M |
| AlphaCentric Advisors LLC | 37,500 | $289.0K |
| Ergoteles LLC | 19,968 | $154.0K |
| Wells Fargo & Company | 44 | $0 |
| Evoke Wealth, LLC | 100 | $0 |